Abstract
Targeted nanoparticle-based gene therapy is a promising alternative to viral gene therapy approaches. The main limitations of non-viral delivery systems currently used are very low transfection efficiency, very high cytotoxicity, and lack of DNA protection leading to premature degradation. The aim of the present work was the development of a stable, biodegradable, nontoxic and plasmid-loaded human serum albumin (HSA)-based nanoparticle system. The nanoparticles were coupled to the cell penetrating peptide (CPP) EB1, a penetratin analogue, in different quantities to improve cell entry and transfection efficiency.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
